Department of Colorectal Surgery, Saint James's Hospital, Dublin, Ireland.
School of Medicine, Trinity College, University of Dublin, Dublin, Ireland.
Colorectal Dis. 2022 Jul;24(7):811-820. doi: 10.1111/codi.16099. Epub 2022 Mar 6.
In low rectal cancers without sphincter involvement a permanent stoma can be avoided without compromising oncological safety. Functional outcomes following coloanal anastomosis (CAA) compared to abdominoperineal excision (APR) may be significantly different. This study examines all available comparative quality of life (QoL) data for patients undergoing CAA versus APR for low rectal cancer.
Published studies with comparative data on QoL outcomes following CAA versus APR for low rectal cancer were extracted from electronic databases. The study was registered with PROSPERO and adhered to PRISMA (Preferred Reporting Items in Systematic Reviews and Meta-analyses) guidelines. Data was combined using random-effects models.
Seven comparative series examined QoL in 527 patients. There was no difference in the numbers receiving neoadjuvant radiotherapy in the APR and CAA groups (OR: 1.19, 95% CI: 0.78-1.81, p = 0.43). CAA was associated with higher mean scores for physical functioning(std mean diff -7.08, 95% CI: -11.92 to -2.25, p = 0.004) and body image (std. mean diff 11.11, 95% CI: 6.04-16.18, p < 0.0001). Male sexual problems were significantly increased in patients who had undergone APR compared to CAA (std. mean diff -16.20, 95% CI: -25.76 to -6.64, p = 0.0009). Patients who had an APR reported more fatigue, dyspnoea and appetite loss. Those who had a CAA reported higher scores for both constipation and diarrhoea.
It is reasonable to offer a CAA to motivated patients where oncological outcomes will not be threatened. QoL outcomes appear to be superior when intestinal continuity is maintained, and permanent stoma avoided.
在无括约肌受累的低位直肠癌中,避免永久性造口术而不影响肿瘤安全性是可行的。与腹会阴切除术(APR)相比,结肠肛管吻合术(CAA)的功能结果可能有显著差异。本研究检查了所有可获得的关于接受低位直肠癌 CAA 与 APR 的患者的生活质量(QoL)比较数据。
从电子数据库中提取了关于低位直肠癌 CAA 与 APR 后 QoL 比较结果的已发表研究。该研究已在 PROSPERO 上注册,并遵循 PRISMA(系统评价和荟萃分析的首选报告项目)指南。使用随机效应模型合并数据。
7 项比较系列研究检查了 527 例患者的 QoL。APR 和 CAA 组接受新辅助放疗的人数没有差异(OR:1.19,95%CI:0.78-1.81,p=0.43)。CAA 与更高的身体功能评分相关(标准平均差-7.08,95%CI:-11.92 至-2.25,p=0.004)和身体形象(标准平均差 11.11,95%CI:6.04-16.18,p<0.0001)。与 CAA 相比,接受 APR 的患者男性性功能问题显著增加(标准平均差-16.20,95%CI:-25.76 至-6.64,p=0.0009)。接受 APR 的患者报告疲劳、呼吸困难和食欲减退更多,而接受 CAA 的患者报告便秘和腹泻的评分更高。
在不会威胁肿瘤学结果的情况下,向有动机的患者提供 CAA 是合理的。当保持肠道连续性并避免永久性造口术时,QoL 结果似乎更好。